Maravai Lifesciences Holdings Inc

Healthcare · Biotechnology

7.40$ +3.2% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

Maravai Lifesciences Holdings Inc (MRVI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 604 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MRVI
Line item	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	578	–	–	650	1,271	1,352	1,601	1,895	1,918	2,043	2,172	2,249	2,282	2,315	2,264	2,268	1,487	1,445	1,448	1,278	1,008	960	897	849	771	713	604
Current Assets	61	25	–	146	332	426	644	687	740	619	759	836	848	766	699	701	700	668	685	679	429	376	360	326	296	252	156
Cash	25	-25	–	36	236	248	375	548	551	431	551	617	632	628	580	580	575	562	573	578	322	285	270	244	217	166	70
Cash & Short-Term Investments	25	25	–	36	236	248	375	548	551	431	551	617	632	628	580	580	575	562	573	578	322	285	270	244	217	166	70
Receivables	18	–	–	73	51	122	84	66	118	120	129	132	147	57	49	49	56	40	39	29	39	28	28	23	25	33	31
Inventory	14	–	–	27	33	47	48	56	52	51	60	62	43	55	47	49	51	50	49	50	50	50	47	45	40	40	41
Property, Plant & Equipment	94	–	–	–	–	105	105	108	46	48	47	48	117	–	207	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	224	–	–	224	224	224	153	153	153	284	284	284	284	327	326	326	326	326	326	172	160	160	129	129	129	129	129
Intangible Assets	198	–	–	183	178	173	125	121	118	235	229	234	217	242	235	228	221	214	207	202	195	200	193	186	152	145	138
Total Liabilities	433	–	–	702	1,116	1,142	1,268	1,441	1,373	1,389	1,398	1,407	1,377	1,415	1,367	1,375	698	667	671	665	431	429	429	417	398	344	248
Current Liabilities	30	–	–	280	131	165	165	114	94	87	113	116	110	125	75	78	87	59	69	63	57	63	70	62	45	43	38
Short-Term Debt	2.5	–	–	2.5	6.0	6.0	6.0	6.0	9.7	5.4	9.8	11	12	12	13	13	13	13	13	13	14	6.3	6.3	5.4	5.4	5.4	1.1
Accounts Payable	7.5	–	–	7.8	8.2	9.8	12	8.9	8.2	10	23	9.5	6.0	4.8	6.7	9.4	11	8.2	13	9.5	12	9.5	12	8.0	2.9	8.5	7.1
Long-Term Debt	335	–	–	349	529	528	527	526	525	524	524	523	522	521	520	520	519	518	517	516	290	289	288	287	286	236	146
Shareholders' Equity	141	145	–	-53	89	113	194	303	315	383	457	504	545	522	521	519	417	411	437	345	325	301	266	245	212	212	205
Retained Earnings	-42	–	–	-52	0.9	24	73	127	185	251	323	367	405	405	398	392	286	274	266	167	141	111	71	46	10	6.4	-6.0
Shares Outstanding	97	89	89	89	114	97	112	122	122	122	122	132	132	132	132	132	132	132	136	142	140	143	144	145	145	146	148

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings